Pharmaceutical Research Associates Inc
Pharmaceutical Research Associates Inc. (PRA Health Sciences) is a leading global contract research organisation headquartered in the United States. Founded in 1976, PRA has established a strong presence in key operational regions, including Europe and Asia, providing comprehensive services across the pharmaceutical and biotechnology industries. Specialising in clinical development, PRA offers a range of services from Phase I-IV clinical trials to data management and regulatory consulting. Their commitment to innovation and patient-centric solutions sets them apart in a competitive market. With a robust portfolio and a reputation for excellence, PRA has achieved significant milestones, including numerous successful drug approvals and partnerships with major pharmaceutical companies. This positions PRA as a trusted partner in advancing healthcare and improving patient outcomes worldwide.
DitchCarbon Score
How does Pharmaceutical Research Associates Inc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Heavy Fuel Oil industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharmaceutical Research Associates Inc's score of 5 is lower than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Research Associates Inc's reported carbon emissions
In 2019, Pharmaceutical Research Associates Inc reported total carbon emissions of approximately 31,296,000 kg CO2e. This figure includes 485,000 kg CO2e from Scope 1 emissions, primarily from stationary combustion, and 8,456,000 kg CO2e from Scope 2 emissions related to purchased electricity. The majority of their emissions, about 22,355,000 kg CO2e, were classified under Scope 3, specifically from business travel. Over the years, the company has seen fluctuations in its emissions. For instance, in 2018, total emissions were approximately 29,912,000 kg CO2e, while in 2017, they reached about 29,641,000 kg CO2e. The highest recorded emissions were in 2016, with approximately 32,428,000 kg CO2e. Despite these figures, there are currently no publicly stated reduction targets or climate pledges from Pharmaceutical Research Associates Inc. This lack of formal commitments may reflect broader industry trends, where many companies are still developing comprehensive strategies to address climate change and reduce their carbon footprints.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | |
|---|---|---|---|---|---|---|
| Scope 1 | 778,650 | 000,000 | 000,000 | 000,000 | 000,000 | 000,000 |
| Scope 2 | 4,234,160 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharmaceutical Research Associates Inc is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
